Ignite Creation Date:
2024-10-25 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06607289
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-01
Brief Title:
National Longitudinal Cohort of Hematological Diseases NICHE - CART
Sponsor:
None
Organization:
None
Study Overview
Official Title:
National Longitudinal Cohort of Hematological Diseases NICHE - CART
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter ambispective longitudinal observational cohort study investigating CAR-T cell therapy in Chinese patients with hematological malignancies A consortium of Phase IV clinical trials and real-world studies of Chimeric antigen receptors CAR T cell therapy will be established in China Patient-level data from these studies will be collected to create a large real-world cohort In addition patients receiving CAR-T cell therapy for hematological malignancies identified from an existing hematology longitudinal cohort study the National Longitudinal Cohort of Hematological Diseases NICHE will also be included in the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None